$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends
01:02pm, Sunday, 10'th Nov 2024
Smith & Nephew's Q3 results led to a 13% share price drop due to reduced FY24 guidance, mainly from lower demand in China. Despite short-term challenges, long-term fundamentals remain strong, presenti
Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript
08:57am, Saturday, 02'nd Nov 2024
Smith & Nephew plc (NYSE:SNN ) Q3 2024 Earnings Conference Call October 31, 2024 4:30 AM ET Company Participants Deepak Nath - CEO & Director John Rogers - CFO & Executive Director Conference Call Par
Smith+Nephew slashes revenue outlook as China headwinds emerge
04:16am, Thursday, 31'st Oct 2024
British medical equipment manufacturer Smith & Nephew PLC (LSE:SN) slashed its full-year revenue outlook to account for a downturn in demand and pricing pressures in the Chinese market. The FTSE 100-l
Smith & Nephew slashes annual revenue forecast on weak China
03:17am, Thursday, 31'st Oct 2024
British medical equipment maker Smith & Nephew cut its annual underlying revenue growth forecast on Thursday to 4.5% from the previous outlook range of 5% to 6%, primarily hurt by challenges in its su
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
09:00am, Wednesday, 16'th Oct 2024
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design
SNN Stock May Gain Following the Co-Marketing Deal With JointVue
01:36pm, Tuesday, 15'th Oct 2024
Smith & Nephew and JointVue announce a co-marketing agreement for the latter's OrthoSonic 3D Surgery Planning Technology.
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System
10:16am, Friday, 11'th Oct 2024
Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
08:00am, Wednesday, 09'th Oct 2024
Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-ma
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
12:51pm, Friday, 20'th Sep 2024
Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.
This stock is 'boring' but has 'fantastic' risk-reward: Scharf
12:40pm, Wednesday, 18'th Sep 2024
Eric Lynch from Scharf Investments explains why he likes the non-tech and utilities sectors.
First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
10:00am, Wednesday, 18'th Sep 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Desig
SNN Stock Declines Despite the Launch of Its Patient-Matched Guides
01:26pm, Friday, 13'th Sep 2024
Smith & Nephew announces the launch of its TOTAL ANKLE Patient-Matched Guides to plan and perform total ankle replacement procedures.
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
10:00am, Tuesday, 10'th Sep 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help
Smith & Nephew Delivering On Its Turnaround Promise
08:30pm, Wednesday, 21'st Aug 2024
The Street has taken notice of Smith & Nephew's turnaround progress, with better than expected revenue and margin results driving share price outperformance. While the ortho business has continued to
Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge
12:25pm, Monday, 12'th Aug 2024
Smith & Nephew (SNN) inks a three-year agreement with InfuSystem (INFU) to distribute its RENASYS EDGE negative pressure wound therapy system.
Sign In
Buy SNN